KYAN has over 150 drugs in inventory to be used research with the Optim.AI™ platform without any lead time.
If your desired drug is not part of our inventory and it is a drug we can test in our assay, our team can source the drug within weeks.
| Nr | Drug Name | Drug Classification | Description |
|---|---|---|---|
| 1 | Abemaciclib | Kinase Inhibitor | CDK4/6 Inhibitor |
| 2 | Acalabrutinib | Kinase Inhibitor | BTK Inhibitor |
| 3 | Afatinib | Kinase Inhibitor | EGFR Inhibitor |
| 4 | Alectinib | Kinase Inhibitor | ALK Inhibitor |
| 5 | Alpelisib | Kinase Inhibitor | PI3K Inhibitor |
| 6 | Anastrozole | Hormonal Therapy | Aromatase Inhibitor |
| 7 | ART558 | Investigational Small Molecule | DNA Polymerase Inhibitor |
| 8 | Atezolizumab | Immunotherapy | Monoclonal Antibody (anti-PD-L1) |
| 9 | Avapritinib | Kinase Inhibitor | PDGFRA / KIT Inhibitor |
| 10 | Avutometinib | Kinase Inhibitor | RAF / MEK Inhibitor |
| 11 | Azacitidine | Antimetabolite | Pyrimidine Analogue (Hypomethylating) |
| 12 | Belantamab mafodotin | Antibody-Drug Conjugate | Anti-BCMA (MMAF Payload) |
| 13 | Belzutifan | Metabolic Inhibitor | HIF-2α Inhibitor |
| 14 | Bendamustine | Alkylating Agent | Nitrogen Mustard / Purine-like |
| 15 | Bezuclastinib | Kinase Inhibitor | KIT Inhibitor |
| 16 | Binimetinib | Kinase Inhibitor | MEK Inhibitor |
| 17 | Bleomycin | Antitumor Antibiotic | Glycopeptide |
| 18 | Bortezomib | Proteasome Inhibitor | - |
| 19 | Brentuximab vedotin | Antibody-Drug Conjugate | Anti-CD30 (MMAE Payload) |
| 20 | Cabozantinib | Kinase Inhibitor | Multi-Kinase (VEGF, MET, RET) |
| 21 | Camonsertib | Investigational Small Molecule | ATR Inhibitor |
| 22 | Capecitabine (5-FU) | Antimetabolite | Pyrimidine Analogue (Prodrug) |
| 23 | Capivasertib | Kinase Inhibitor | AKT Inhibitor |
| 24 | Carboplatin | Alkylating Agent | Platinum Analogue |
| 25 | Carfilzomib | Proteasome Inhibitor | - |
| 26 | Carmustine | Alkylating Agent | Nitrosourea |
| 27 | Ceritinib | Kinase Inhibitor | ALK Inhibitor |
| 28 | Cetuximab | Immunotherapy | Monoclonal Antibody (anti-EGFR) |
| 29 | Chlorambucil | Alkylating Agent | Nitrogen Mustard |
| 30 | Cisplatin | Alkylating Agent | Platinum Analogue |
| 31 | Cladribine | Antimetabolite | Purine Analogue |
| 32 | Clofarabine | Antimetabolite | Purine Analogue |
| 33 | Cobimetinib | Kinase Inhibitor | MEK Inhibitor |
| 34 | Copanlisib | Kinase Inhibitor | PI3K Inhibitor |
| 35 | Crizotinib | Kinase Inhibitor | ALK / ROS1 Inhibitor |
| 36 | Cyclophosphamide | Alkylating Agent | Nitrogen Mustard |
| 37 | Cyclosporine | Immunosuppressant | Calcineurin Inhibitor |
| 38 | Cytarabine | Antimetabolite | Pyrimidine Analogue |
| 39 | Dabrafenib | Kinase Inhibitor | BRAF Inhibitor |
| 40 | Dacarbazine | Alkylating Agent | Triazene / DNA Methylating Agent |
| 41 | Dacomitinib | Kinase Inhibitor | EGFR Inhibitor |
| 42 | Daratumumab | Immunotherapy | Monoclonal Antibody (Anti-CD38) |
| 43 | Daraxonrasib | RAS(ON) inhibitor | Active RAS proteins |
| 44 | Dasatinib | Kinase Inhibitor | BCR-ABL / Src Inhibitor |
| 45 | Datopotamab deruxtecan | Antibody-Drug Conjugate | Anti-Trop-2 (DXd Payload) |
| 46 | Daunorubicin | Antitumor Antibiotic | Anthracycline |
| 47 | Decitabine | Antimetabolite | Pyrimidine Analogue (Hypomethylating) |
| 48 | Defactinib | Kinase Inhibitor | FAK Inhibitor |
| 49 | Dexamethasone | Corticosteroid | Glucocorticoid |
| 50 | Docetaxel | Anti-Microtubule Agent | Taxane |
| 51 | Doxorubicin | Antitumor Antibiotic | Anthracycline |
| 52 | Duvelisib | Kinase Inhibitor | PI3K / Delta-Gamma Inhibitor |
| 53 | Elranatamab | Immunotherapy | Bispecific Antibody (CD3 x BCMA) |
| 54 | Enasidenib | Metabolic Inhibitor | IDH2 Inhibitor |
| 55 | Encorafenib | Kinase Inhibitor | BRAF Inhibitor |
| 56 | Entrectinib | Kinase Inhibitor | NTRK / ROS1 Inhibitor |
| 57 | Epcoritamab | Immunotherapy | Bispecific Antibody (CD3 x CD20) |
| 58 | Epirubicin | Antitumor Antibiotic | Anthracycline |
| 59 | Eribulin | Anti-Microtubule Agent | Non-Taxane (Halichondrin B Analog) |
| 60 | Erlotinib | Kinase Inhibitor | EGFR Inhibitor |
| 61 | Etoposide | Topoisomerase Inhibitor | Topoisomerase II Inhibitor |
| 62 | Everolimus | mTOR Inhibitor | mTORC1 Inhibitor |
| 63 | Fludarabine | Antimetabolite | Purine Analogue |
| 64 | Fruquintinib | Kinase Inhibitor | VEGFR Inhibitor |
| 65 | Fulvestrant | Hormonal Therapy | Estrogen Receptor Degrader (SERD) |
| 66 | Gefitinib | Kinase Inhibitor | EGFR Inhibitor |
| 67 | Gemcitabine | Antimetabolite | Pyrimidine Analogue |
| 68 | Gilteritinib | Kinase Inhibitor | FLT3 Inhibitor |
| 69 | Glofitamab | Immunotherapy | Bispecific Antibody (CD3 x CD20) |
| 70 | HX009 | Immunotherapy | Bispecific Antibody (PD-1 x CD47) |
| 71 | Idarubicin | Antitumor Antibiotic | Anthracycline |
| 72 | Ifosfamide | Alkylating Agent | Nitrogen Mustard |
| 73 | Imatinib | Kinase Inhibitor | BCR-ABL Inhibitor |
| 74 | Inobrodib | Epigenetic Modifier | p300/CBP Inhibitor |
| 75 | Ipilimumab | Immunotherapy | Monoclonal Antibody (Anti-CTLA-4) |
| 76 | Irinotecan (SN-38) | Topoisomerase Inhibitor | Topoisomerase I Inhibitor |
| 77 | Isatuximab | Immunotherapy | Monoclonal Antibody (Anti-CD38) |
| 78 | Ivosidenib | Metabolic Inhibitor | IDH1 Inhibitor |
| 80 | Ixazomib | Proteasome Inhibitor | - |
| 79 | L-Asparaginase | Enzyme | Amino Acid Depletion |
| 81 | Lapatinib | Kinase Inhibitor | EGFR / HER2 Inhibitor |
| 82 | Lazertinib | Kinase Inhibitor | EGFR Inhibitor |
| 83 | Lenalidomide | Immunomodulator (IMiD) | E3 Ligase Ligand |
| 84 | Lenvatinib | Kinase Inhibitor | Multi-Kinase (VEGF, FGF) |
| 85 | Letrozole | Hormonal Therapy | Aromatase Inhibitor |
| 86 | Leucovorin | Folic acid analog | - |
| 87 | Lomustine | Alkylating Agent | Nitrosourea |
| 88 | Loncastuximab tesirine | Antibody-Drug Conjugate | Anti-CD19 (PBD Payload) |
| 89 | Megestrol Acetate | Hormonal Therapy | Progesterone and glucocorticoid agonist |
| 90 | Melphalan | Alkylating Agent | Nitrogen Mustard |
| 91 | Methotrexate | Antimetabolite | Antifolate |
| 92 | Midostaurin | Kinase Inhibitor | FLT3 Inhibitor |
| 93 | Mirvetuximab soravtansine | Antibody-Drug Conjugate | Anti-Folate Receptor Alpha (DM4 payload) |
| 94 | Mitomycin C | Antitumor Antibiotic | Alkylating-like Agent |
| 95 | Mitoxantrone | Antitumor Antibiotic | Anthracenedione |
| 96 | Mogamulizumab | Immunotherapy | Monoclonal Antibody (Anti-CCR4) |
| 97 | Momelotinib | Kinase Inhibitor | JAK1 / JAK2 / ACVR1 Inhibitor |
| 98 | Neratinib | Kinase Inhibitor | EGFR / HER2 Inhibitor |
| 99 | Nilotinib | Kinase Inhibitor | BCR-ABL Inhibitor |
| 100 | Niraparib | PARP Inhibitor | - |
| 101 | Obinutuzumab | Immunotherapy | Monoclonal Antibody (Anti-CD20, Type II) |
| 102 | Olaparib | PARP Inhibitor | - |
| 103 | Olverembatinib | Kinase Inhibitor | BCR-ABL Inhibitor |
| 104 | Oxaliplatin | Alkylating Agent | Platinum Analogue |
| 105 | Paclitaxel | Anti-Microtubule Agent | Taxane |
| 106 | Palbociclib | Kinase Inhibitor | CDK4/6 Inhibitor |
| 107 | Panobinostat | Epigenetic Modifier | HDAC Inhibitor |
| 108 | Pazopanib | Kinase Inhibitor | Multi-Kinase (VEGF, PDGF) |
| 109 | Pembrolizumab | Immunotherapy | Monoclonal Antibody (Anti-PD-1) |
| 110 | Pemetrexed | Antimetabolite | Antifolate |
| 111 | Pemigatinib | Kinase Inhibitor | FGFR Inhibitor |
| 112 | Pertuzumab | Immunotherapy | Monoclonal Antibody (Anti-HER2, Dimerization Inhibitor) |
| 113 | Pimitespib | Investigational Small Molecule | HSP90 Inhibitor |
| 114 | Polatuzumab vedotin | Antibody-Drug Conjugate | Anti-CD79b (MMAE Payload) |
| 115 | Pomalidomide | Immunomodulator (IMiD) | Thalidomide Analog |
| 116 | Ponatinib | Kinase Inhibitor | BCR-ABL Inhibitor |
| 117 | Pralatrexate | Antimetabolite | Antifolate |
| 118 | Procarbazine | Alkylating Agent | Methylhydrazine Derivative |
| 119 | Quizartinib | Kinase Inhibitor | FLT3 Inhibitor |
| 120 | Regorafenib | Kinase Inhibitor | Multi-Kinase (VEGF, RAF) |
| 121 | Retinoic Acid | Differentiation Agent | Retinoid (Vitamin A derivative) |
| 122 | Revumenib | Epigenetic Modifier | Menin Inhibitor |
| 123 | Rinatabart sesutecan | Antibody-Drug Conjugate | Anti-FRα (Exatecan Payload) |
| 124 | Ripretinib | Kinase Inhibitor | KIT / PDGFRA Inhibitor |
| 125 | Rituximab | Immunotherapy | Monoclonal Antibody (Anti-CD20, Type I) |
| 126 | Rivoceranib | Kinase Inhibitor | VEGFR2 Inhibitor |
| 127 | Rogaratinib | Kinase Inhibitor | FGFR Inhibitor |
| 128 | Romidepsin | Epigenetic Modifier | HDAC Inhibitor |
| 129 | RP-6306 | Investigational Small Molecule | PKMYT1 Inhibitor |
| 130 | Rucaparib | PARP Inhibitor | - |
| 131 | Ruxolitinib | Kinase Inhibitor | JAK1 / JAK2 Inhibitor |
| 132 | Sacituzumab govitecan | Antibody-Drug Conjugate | Anti-Trop-2 (SN-38 Payload) |
| 133 | Selinexor | Nuclear Export Inhibitor | XPO1 Inhibitor |
| 134 | Sorafenib | Kinase Inhibitor | Multi-Kinase (VEGF, RAF) |
| 135 | Sotorasib | Kinase Inhibitor | KRAS G12C Inhibitor |
| 136 | Sunitinib | Kinase Inhibitor | Multi-Kinase (VEGF, PDGF) |
| 137 | Tafasitamab | Immunotherapy | Monoclonal Antibody (Anti-CD19) |
| 138 | Talquetamab | Immunotherapy | Bispecific Antibody (CD3 x GPRC5D) |
| 139 | Tamoxifen | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) |
| 140 | Teclistamab | Immunotherapy | Bispecific Antibody (CD3 x BCMA) |
| 141 | Temozolomide | Alkylating Agent | Imidazotetrazine Derivative |
| 142 | Thalidomide | Immunomodulator (IMiD) | Angiogenesis Inhibitor |
| 143 | Tipiracil | Antimetabolite | Pyrimidine Analogue (Thymidine Phosphorylase) |
| 144 | Topotecan | Topoisomerase Inhibitor | Topoisomerase I Inhibitor |
| 145 | Trabectedin | Alkylating Agent | DNA Minor Groove Binder |
| 146 | Trametinib | Kinase Inhibitor | MEK Inhibitor |
| 147 | Trastuzumab | Immunotherapy | Monoclonal Antibody (Anti-HER2) |
| 148 | Trastuzumab Deruxtecan | Antibody-Drug Conjugate | Anti-HER2 (DXd Payload) |
| 149 | Trastuzumab Emtansine | Antibody-Drug Conjugate | Anti-HER2 (DM1 Payload) |
| 150 | Trifluridine | Antimetabolite | Pyrimidine Analogue |
| 151 | Tucatinib | Kinase Inhibitor | HER2 Inhibitor |
| 152 | Valemetostat | Epigenetic Modifier | EZH1 / EZH2 Inhibitor |
| 153 | Valproic Acid | Epigenetic Modifier | HDAC Inhibitor |
| 154 | Venetoclax | Apoptosis Inducer | BCL-2 Inhibitor |
| 155 | Vincristine | Anti-Microtubule Agent | Vinca Alkaloid |
| 156 | Vinorelbine | Anti-Microtubule Agent | Vinca Alkaloid |
| 157 | Zanubrutinib | Kinase Inhibitor | BTK Inhibitor |
| 158 | Zoldonrasib | Investigational Small Molecule | RAS Inhibitor |